Quercetin protects liver injury induced by bile duct ligation via attenuation of Rac1 and NADPH oxidase1 expression in rats

Hepatobiliary Pancreat Dis Int. 2017 Feb;16(1):88-95. doi: 10.1016/s1499-3872(16)60164-9.

Abstract

Background: Bile duct ligation (BDL) and subsequent cholestasis are correlated with oxidative stress, hepatocellular injury and fibrosis. Quercetin is a flavonoid with antifibrotic, and hepatoprotective properties. However, the molecular mechanism underlying quercetin-mediated hepatoprotection is not fully understood. The current study was to evaluate mechanisms of hepatoprotective effect of quercetin in BDL rat model.

Methods: We divided male Wistar rats into 4 groups (n=8 for each): sham, sham+quercetin (30 mg/kg per day), BDL, and BDL+quercetin (30 mg/kg per day). Four weeks later, the rats were sacrificed, the blood was collected for liver enzyme measurements and liver for the measurement of Rac1, Rac1-GTP and NOX1 mRNA and protein levels by quantitative PCR and Western blotting, respectively.

Results: Quercetin significantly alleviated liver injury in BDL rats as evidenced by histology and reduced liver enzymes. Furthermore, the mRNA and protein expression of Rac1, Rac1-GTP and NOX1 were significantly increased in BDL rats compared with those in the sham group (P<0.05); quercetin treatment reversed these variables back toward normal (P<0.05). Another interesting finding was that the antioxidant markers e.g. superoxide dismutase and catalase were elevated in quercetin-treated BDL rats compared to BDL rats (P<0.05).

Conclusion: Quercetin demonstrated hepatoprotective activity against BDL-induced liver injury through increasing antioxidant capacity of the liver tissue, while preventing the production of Rac1, Rac1-GTP and NOX1 proteins.

MeSH terms

  • Actins / genetics
  • Actins / metabolism
  • Animals
  • Antioxidants / pharmacology*
  • Catalase / metabolism
  • Cholestasis / complications
  • Cholestasis / drug therapy*
  • Cholestasis / enzymology
  • Cholestasis / pathology
  • Collagen Type I / genetics
  • Collagen Type I / metabolism
  • Cytoprotection
  • Down-Regulation
  • Hydroxyproline / metabolism
  • Liver / drug effects*
  • Liver / enzymology
  • Liver / pathology
  • Liver Cirrhosis, Experimental / enzymology
  • Liver Cirrhosis, Experimental / etiology
  • Liver Cirrhosis, Experimental / pathology
  • Liver Cirrhosis, Experimental / prevention & control*
  • Male
  • NADH, NADPH Oxidoreductases / genetics
  • NADH, NADPH Oxidoreductases / metabolism*
  • NADPH Oxidase 1
  • Oxidative Stress / drug effects*
  • Protein Carbonylation / drug effects
  • Quercetin / pharmacology*
  • Rats, Wistar
  • Signal Transduction / drug effects
  • Sulfhydryl Compounds / metabolism
  • Superoxide Dismutase / metabolism
  • Transforming Growth Factor beta1 / genetics
  • Transforming Growth Factor beta1 / metabolism
  • rac1 GTP-Binding Protein / genetics
  • rac1 GTP-Binding Protein / metabolism*

Substances

  • Actins
  • Antioxidants
  • Collagen Type I
  • Sulfhydryl Compounds
  • Tgfb1 protein, rat
  • Transforming Growth Factor beta1
  • smooth muscle actin, rat
  • Quercetin
  • Catalase
  • Superoxide Dismutase
  • NADH, NADPH Oxidoreductases
  • NADPH Oxidase 1
  • NOX1 protein, rat
  • Rac1 protein, rat
  • rac1 GTP-Binding Protein
  • Hydroxyproline